Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

FOSINOPRIL IMPURITY C CRS (10MG)

FOSINOPRIL IMPURITY C CRS (10MG)

NA

DISCOVER
FOSINOPRIL IMPURITY D CRS (10MG)

FOSINOPRIL IMPURITY D CRS (10MG)

NA

DISCOVER
FOSINOPRIL IMPURITY I CRS (5 MG)

FOSINOPRIL IMPURITY I CRS (5 MG)

123599-82-6

DISCOVER
FOSINOPRIL IMPURITY K CRS (5 MG)

FOSINOPRIL IMPURITY K CRS (5 MG)

NA

DISCOVER
LISINOPRIL IMPURITY F CRS (0.01 MG)

LISINOPRIL IMPURITY F CRS (0.01 MG)

NA

DISCOVER
ECONAZOLE CRS (10 MG)

ECONAZOLE CRS (10 MG)

27220-47-9

DISCOVER
NIMESULIDE FOR PEAK IDENTIFICATION CRS (10 MG)

NIMESULIDE FOR PEAK IDENTIFICATION CRS (10 MG)

51803-78-2

DISCOVER
SULFINPYRAZONE FOR SYSTEM SUITABILITY CRS (0.5 MG)

SULFINPYRAZONE FOR SYSTEM SUITABILITY CRS (0.5 MG)

57-96-5

DISCOVER
DOBUTAMINE IMPURITY MIXTURE CRS (0.1 MG)

DOBUTAMINE IMPURITY MIXTURE CRS (0.1 MG)

NA

DISCOVER
AZATHIOPRINE IMPURITY A CRS (10 MG)

AZATHIOPRINE IMPURITY A CRS (10 MG)

4531-54-8

DISCOVER
ZIPRASIDONE FOR SYSTEM SUITABILITY 2 CRS (0.465 MG)

ZIPRASIDONE FOR SYSTEM SUITABILITY 2 CRS (0.465 MG)

138982-67-9

DISCOVER
FOLIC ACID IMPURITY A CRS (25MG)

FOLIC ACID IMPURITY A CRS (25MG)

4271-30-1

DISCOVER